var data = {
    testTitle:"Chapter 11. Neuromuscular Blocking Agents",
    heading: "",
    content: "",
    innerContent: "<p>To start the test, please click on the <b>Begin </b>button. You will have two attempts to select the correct answer for each question.</p> <p><b>Good luck!</b></p>",
    buttonText: "Begin",
    nMaxPage: 10,
    aBottomNavCustomLabels:['1','2','3','4','5','6','7','8','9','10'],
     enableBottomNavCustomLabels: true,
    enableBottomNavCustomLabels: true,
    questionsList: [{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>1.</span> The movement of ACh-containing vesicles toward the active zone is enhanced by:</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. Botulinum toxin.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "B. Nondepolarizing neuromuscular blockers.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "C. Acetylcholine.",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>Acetylcholine binds to presynaptic neuronal nAChRs in a positive feedback loop, causing migration of Ach vesicles to the active zone. Nondepolarizing NMBs bind presynaptic neuronal nAChRs impeding this process, leading to TOF fade. Botulinum toxin degrades the proteins that facilitate Ach vesicle movement to the active zone causing weakness. Calcium influx cause Ach vesicles in the active zone to fuse with the nerve membrane resulting in release of Ach into the cleft. Magnesium acts as a false transmitter for calcium, slowing calcium influx and hindering ACh release from vesicles.</p>"
        },
		{
            text : "D. Magnesium.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>Acetylcholine binds to presynaptic neuronal nAChRs in a positive feedback loop, causing migration of Ach vesicles to the active zone. Nondepolarizing NMBs bind presynaptic neuronal nAChRs impeding this process, leading to TOF fade. Botulinum toxin degrades the proteins that facilitate Ach vesicle movement to the active zone causing weakness. Calcium influx cause Ach vesicles in the active zone to fuse with the nerve membrane resulting in release of Ach into the cleft. Magnesium acts as a false transmitter for calcium, slowing calcium influx and hindering ACh release from vesicles.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>2.</span> A more potent NMBA has which of the following characteristics?</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. Smaller ED95",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>A</span></b></p><p class='ANSbTXT'>Fewer molecules are required for effect with more potent NMBs; thus, the effective dose for 95% twitch reduction in half the patients (ED<sub>95</sub>) is smaller. Potency is inversely related to speed of onset; thus, more potent NMBs have slower onset. Potency does not affect duration.</p>"
        },
		{
            text : "B. Faster onset",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "C. More molecules per equivalent dose",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "D. Prolonged duration",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>A</span></b></p><p class='ANSbTXT'>Fewer molecules are required for effect with more potent NMBs; thus, the effective dose for 95% twitch reduction in half the patients (ED<sub>95</sub>) is smaller. Potency is inversely related to speed of onset; thus, more potent NMBs have slower onset. Potency does not affect duration.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>3.</span> All of the following are associated with a succinylcholine-induced phase II block EXCEPT:</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. No fade with train-of-four stimulation.",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>A</span></b></p><p class='ANSbTXT'>Phase II block occurs with relatively large doses of succinylcholine and shares characteristics with a nondepolarizing block, such as fade with train-of-four stimulation. Lack of efficient metabolism of succinylcholine, which occurs with atypical pseudocholinesterase or a deficiency of normal pseudocholinesterase, leads to build up of succinylcholine even when normal doses are administered; this can result in a phase II block.</p>"
        },
		{
            text : "B. Atypical pseudocholinesterase.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "C. Large doses of succinylcholine.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "D. Plasma cholinesterase deficiency.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>A</span></b></p><p class='ANSbTXT'>Phase II block occurs with relatively large doses of succinylcholine and shares characteristics with a nondepolarizing block, such as fade with train-of-four stimulation. Lack of efficient metabolism of succinylcholine, which occurs with atypical pseudocholinesterase or a deficiency of normal pseudocholinesterase, leads to build up of succinylcholine even when normal doses are administered; this can result in a phase II block.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>4.</span> Which of following is most likely true about post-succinylcholine myalgias?</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. They correlate with the presence of fasciculations.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "B. They occur in 1% of patients.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "C. Lidocaine is an effective prophylaxis.",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>Myalgias are reported in up to half the patients who receive succinylcholine. There is no correlation between fasciculations and the development of myalgias. Lidocaine and nonsteroidal anti-inflammatory drugs are effective pharmacologic prophylactic options. Interestingly, patients receiving larger doses of succinylcholine are less likely to experience myalgias.</p>"
        },
		{
            text : "D. Smaller doses reduce the risk.",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>Myalgias are reported in up to half the patients who receive succinylcholine. There is no correlation between fasciculations and the development of myalgias. Lidocaine and nonsteroidal anti-inflammatory drugs are effective pharmacologic prophylactic options. Interestingly, patients receiving larger doses of succinylcholine are less likely to experience myalgias.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>5.</span> You are intubating a 183&#x00A0;cm (6&#x00A0;ft), 160&#x00A0;kg male trauma patient utilizing the rapid sequence induction and intubation technique with succinylcholine. Which is the appropriate dose (assume 1.5&#x00A0;mg/kg)?</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. 240&#x00A0;mg (actual body weight)",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>A</span></b></p><p class='ANSbTXT'>Succinylcholine is dosed based on actual body weight, as are the benzylisoquinoline neuromuscular blockers (cisatracurium and mivacurium). The aminosteroidal neuromuscular blockers (rocuronium and vecuronium) are dosed based on ideal body weight.</p>"
        },
		{
            text : "B. 115&#x00A0;mg (ideal body weight)",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "C. 110&#x00A0;mg (adjusted body weight, ideal body weight&#x00A0;+&#x00A0;0.4&#x00A0;&#x00D7;&#x00A0;[total body weight&#x00A0;&#x2212;&#x00A0;ideal body weight])",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "D. 135&#x00A0;mg (fat-free mass)",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>A</span></b></p><p class='ANSbTXT'>Succinylcholine is dosed based on actual body weight, as are the benzylisoquinoline neuromuscular blockers (cisatracurium and mivacurium). The aminosteroidal neuromuscular blockers (rocuronium and vecuronium) are dosed based on ideal body weight.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>6.</span> By direct effects on the postjunctional receptors, which of the following inhalational agents potentiates the effects of rocuronium the most?</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. Sevoflurane",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "B. Desflurane",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>B</span></b></p><p class='ANSbTXT'>Desflurane potentiates neuromuscular blockade more than sevoflurane and isoflurane. Nitrous oxide potentiates neuromuscular blockade the least of the listed agents.</p>"
        },
		{
            text : "C. Isoflurane",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "D. Nitrous oxide",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>B</span></b></p><p class='ANSbTXT'>Desflurane potentiates neuromuscular blockade more than sevoflurane and isoflurane. Nitrous oxide potentiates neuromuscular blockade the least of the listed agents.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>7.</span> Which nondepolarizing muscle relaxant is metabolized by the same mechanism as succinylcholine?</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. Rocuronium",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "B. Cisatracurium",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "C. Mivacurium",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>Mivacurium and succinylcholine are metabolized by pseudocholinesterase. Rocuronium and vecuronium are eliminated via a combination of hepatic and renal routes. Cisatracurium is eliminated via Hoffman degradation and nonspecific ester hydrolysis.</p>"
        },
		{
            text : "D. Vecuronium",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>Mivacurium and succinylcholine are metabolized by pseudocholinesterase. Rocuronium and vecuronium are eliminated via a combination of hepatic and renal routes. Cisatracurium is eliminated via Hoffman degradation and nonspecific ester hydrolysis.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>8.</span> At the end of a robotic prostatectomy you check the train-of-four response and recognize four twitches with fade. This correlates with which of the following? (TOFR&#x00A0;=&#x00A0;train-of-four ratio.)</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. TOFR &#x2265;90%",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "B. TOFR 40 to 90%",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "C. TOFR &#x003C;40%",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>TOFR cannot be determined by objective assessment. However, human detection of a reduction in the fourth twitch (TOF with fade) correlates with a measured TOFR less than 40%. If there is no fade, then all that can be determined is that the TOFR is greater than 40%. Based solely on this objective assessment, it cannot be determined if the TOFR is acceptable for extubation (TOFR &#x2265; 90%). Quantitative monitoring is required to determine if the TOFR is above 90%.</p>"
        },
		{
            text : "D. Cannot be determined",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>TOFR cannot be determined by objective assessment. However, human detection of a reduction in the fourth twitch (TOF with fade) correlates with a measured TOFR less than 40%. If there is no fade, then all that can be determined is that the TOFR is greater than 40%. Based solely on this objective assessment, it cannot be determined if the TOFR is acceptable for extubation (TOFR &#x2265; 90%). Quantitative monitoring is required to determine if the TOFR is above 90%.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>9.</span> Neostigmine is the only reversal agent available in your hospital. At what train-of-four count is it appropriate to use this agent to reverse neuromuscular blockade?</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. 2",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "B. 1",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "C. 4",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>The practice of reversing deep levels of neuromuscular block with neostigmine is very likely the main contributing factor in the ongoing problem of postoperative residual paralysis. To combat this disturbing trend, experts recommend waiting until the fourth twitch has returned before reversing with neostigmine. If neostigmine is used to reverse at deeper levels of block, then quantitative monitoring should be used to verify that a TOFR &#x2265; 90% has been attained before extubation.</p>"
        },
		{
            text : "D. 3",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>C</span></b></p><p class='ANSbTXT'>The practice of reversing deep levels of neuromuscular block with neostigmine is very likely the main contributing factor in the ongoing problem of postoperative residual paralysis. To combat this disturbing trend, experts recommend waiting until the fourth twitch has returned before reversing with neostigmine. If neostigmine is used to reverse at deeper levels of block, then quantitative monitoring should be used to verify that a TOFR &#x2265; 90% has been attained before extubation.</p>"
    },
		{
        step:"",
        question: "<p class='RQMNLMFIRST'><b><span class='que0'>10.</span> A 65&#x00A0;kg woman has undergone a left upper lobectomy where the surgeon requested deep neuromuscular blockade. The patient received rocuronium and has a TOF count of 0 and 5 post-tetanic twitches (PTC&#x00A0;=&#x00A0;5) at the end of the case. What dose of sugammadex should be used for reversal?</b></p>",
        input: false,
        isDraggable: false,
        queImage:"",
		queImageThumbnail:false,
        allowCaption:false,
        allowedAttempts:2,
        captiontext:"",
        queImageWidth:30,
        queImageHeight:20,
        allowAnsImages:false,
        answers:[{
            text : "A. 16&#x00A0;mg/kg",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "B. 4&#x00A0;mg/kg",
            correct : true,
            feedbackText : "<span>Good!</span> <p class='ANSbNL1'><b><span class='que0'>B</span></b></p><p class='ANSbTXT'>The manufacturer-recommended dose is 16&#x00A0;mg/kg <br/>for profound block (zero posttetanic twitches, PTC&#x00A0;=&#x00A0;0). When at least one twitch can be elicited after tetany (PTC &#x2265; 1) up to a TOF count of 1, the recommended dose is 4&#x00A0;mg/kg. After the second twitch has returned (TOFC &#x2265; 2), then only 2&#x00A0;mg/kg is needed.</p>"
        },
		{
            text : "C. 2&#x00A0;mg/kg",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
        },
		{
            text : "D. 1&#x00A0;mg/kg",
            correct : false,
            feedbackText : "<b>Try Again</b>. Please close (X) this box and <b>Try Again</b> button will appear."
         }],
        remFeedbackText: "<b>Here is the correct answer!</b> <p class='ANSbNL1'><b><span class='que0'>B</span></b></p><p class='ANSbTXT'>The manufacturer-recommended dose is 16&#x00A0;mg/kg <br/>for profound block (zero posttetanic twitches, PTC&#x00A0;=&#x00A0;0). When at least one twitch can be elicited after tetany (PTC &#x2265; 1) up to a TOF count of 1, the recommended dose is 4&#x00A0;mg/kg. After the second twitch has returned (TOFC &#x2265; 2), then only 2&#x00A0;mg/kg is needed.</p>"
    }
   ],
    resultContent: "<p>You can choose to retake the quiz or Review it. Click <b>Retake</b> to take the quiz from the beginning.</p>",
    retultResetButtonText: "Retake",
    retultResetButtonText2: "Review"
};
